These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26744530)

  • 41. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
    Satoh H; Moriguchi T; Takai J; Ebina M; Yamamoto M
    Cancer Res; 2013 Jul; 73(13):4158-68. PubMed ID: 23610445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
    Le Roux Ö; Everitt JI; Counter CM
    PLoS One; 2024; 19(3):e0292189. PubMed ID: 38547169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
    Chalaris A; Rabe B; Paliga K; Lange H; Laskay T; Fielding CA; Jones SA; Rose-John S; Scheller J
    Blood; 2007 Sep; 110(6):1748-55. PubMed ID: 17567983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukotriene B4 receptor-2 contributes to KRAS-driven lung tumor formation by promoting interleukin-6-mediated inflammation.
    Jang JH; Park D; Park GS; Kwak DW; Park J; Yu DY; You HJ; Kim JH
    Exp Mol Med; 2021 Oct; 53(10):1559-1568. PubMed ID: 34635780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.
    Ruwanpura SM; McLeod L; Dousha LF; Seow HJ; Alhayyani S; Tate MD; Deswaerte V; Brooks GD; Bozinovski S; MacDonald M; Garbers C; King PT; Bardin PG; Vlahos R; Rose-John S; Anderson GP; Jenkins BJ
    Am J Respir Crit Care Med; 2016 Dec; 194(12):1494-1505. PubMed ID: 27373892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Requirement for epithelial p38α in KRAS-driven lung tumor progression.
    Vitos-Faleato J; Real SM; Gutierrez-Prat N; Villanueva A; Llonch E; Drosten M; Barbacid M; Nebreda AR
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2588-2596. PubMed ID: 31969449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47.
    Hu H; Cheng R; Wang Y; Wang X; Wu J; Kong Y; Zhan S; Zhou Z; Zhu H; Yu R; Liang G; Wang Q; Zhu X; Zhang CY; Yin R; Yan C; Chen X
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36413402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
    Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rare codons capacitate Kras-driven de novo tumorigenesis.
    Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
    J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.
    Welcker D; Jain M; Khurshid S; Jokić M; Höhne M; Schmitt A; Frommolt P; Niessen CM; Spiro J; Persigehl T; Wittersheim M; Büttner R; Fanciulli M; Schermer B; Reinhardt HC; Benzing T; Höpker K
    Oncogene; 2018 Mar; 37(11):1503-1518. PubMed ID: 29321668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer.
    Caetano MS; Hassane M; Van HT; Bugarin E; Cumpian AM; McDowell CL; Cavazos CG; Zhang H; Deng S; Diao L; Wang J; Evans SE; Behrens C; Wistuba II; Fuqua SAW; Lin H; Stabile LP; Watowich SS; Kadara H; Moghaddam SJ
    Nat Commun; 2018 Nov; 9(1):4589. PubMed ID: 30389925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian disruption enhances HSF1 signaling and tumorigenesis in
    Pariollaud M; Ibrahim LH; Irizarry E; Mello RM; Chan AB; Altman BJ; Shaw RJ; Bollong MJ; Wiseman RL; Lamia KA
    Sci Adv; 2022 Sep; 8(39):eabo1123. PubMed ID: 36170373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations.
    Ha DP; Huang B; Wang H; Rangel DF; Van Krieken R; Liu Z; Samanta S; Neamati N; Lee AS
    Neoplasia; 2022 Nov; 33():100837. PubMed ID: 36162331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response.
    Qiu H; Jin BM; Wang ZF; Xu B; Zheng QF; Zhang L; Zhu LY; Shi S; Yuan JB; Lin X; Gao SB; Jin GH
    Nat Commun; 2020 Feb; 11(1):1009. PubMed ID: 32081882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
    Schreiber S; Aden K; Bernardes JP; Conrad C; Tran F; Höper H; Volk V; Mishra N; Blase JI; Nikolaus S; Bethge J; Kühbacher T; Röcken C; Chen M; Cottingham I; Petri N; Rasmussen BB; Lokau J; Lenk L; Garbers C; Feuerhake F; Rose-John S; Waetzig GH; Rosenstiel P
    Gastroenterology; 2021 Jun; 160(7):2354-2366.e11. PubMed ID: 33667488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AMPKα loss promotes KRAS-mediated lung tumorigenesis.
    La Montagna M; Shi L; Magee P; Sahoo S; Fassan M; Garofalo M
    Cell Death Differ; 2021 Sep; 28(9):2673-2689. PubMed ID: 34040167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer.
    Dosch AR; Singh S; Dai X; Mehra S; Silva IC; Bianchi A; Srinivasan S; Gao Z; Ban Y; Chen X; Banerjee S; Nagathihalli NS; Datta J; Merchant NB
    Mol Cancer Ther; 2021 Nov; 20(11):2280-2290. PubMed ID: 34518296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.
    Ancrile B; Lim KH; Counter CM
    Genes Dev; 2007 Jul; 21(14):1714-9. PubMed ID: 17639077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.
    Brichkina A; Bertero T; Loh HM; Nguyen NT; Emelyanov A; Rigade S; Ilie M; Hofman P; Gaggioli C; Bulavin DV
    Genes Dev; 2016 Dec; 30(23):2623-2636. PubMed ID: 28007785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice.
    Parikh N; Shuck RL; Gagea M; Shen L; Donehower LA
    Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29047229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.